Publications by authors named "N Kille"

Background: Citizen science as an approach to merge society and science is not a new paradigm. Yet it is not common in public health, epidemiology, or medical sciences. SMARAGD (Sensors for Measuring Aerosols and ReActive Gases to Deduce health effects) assesses air pollution at participants' homes or workplaces in Cologne, Germany, as feasibility study with a citizen science approach.

View Article and Find Full Text PDF

There is considerable evidence that centrally acting α2A adrenergic receptor agonists can attenuate impairments in executive function that result from dysfunction of the prefrontal cortex. Such positive effects resulted in the recent approval by the United States Food and Drug Administration (FDA) of the α2A agonists clonidine and guanfacine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD), but also suggest that they could have beneficial effects in substance abuse disorders and other neuropsychiatric conditions. The purpose of this study was to evaluate guanfacine for its ability to attenuate behavioral alterations associated with acute cocaine exposure in rats trained to perform a task of sustained attention, the five choice serial reaction time task (5C-SRTT) and monkeys trained to perform a task of working/short term memory, the delayed match to sample (DMTS) task.

View Article and Find Full Text PDF

The development of novel therapeutic agents for disorders of cognition such as Alzheimer's disease (AD) is of paramount importance given the ever-increasing elderly population, however; there is also considerable interest in any strategy that might enhance the clinical efficacy of currently available treatments. The purpose of this study was to evaluate an adjunctive treatment strategy to memory enhancement, namely combining the commonly prescribed acetylcholinesterase inhibitor (AChEI) donepezil, with a positive allosteric modulator (PAM) of α7 nicotinic-acetylcholine receptors (α7-nAChRs), PNU-120596. The treatment strategy was evaluated in a (non-spatial) spontaneous novel object recognition (NOR) task in young rats; a water maze spatial learning and recall procedure in aged, cognitively-impaired rats, and a delayed match to sample (working/short term memory) task in aged rhesus monkeys.

View Article and Find Full Text PDF

Introduction: The alpha(2)-adrenergic receptor agonist clonidine was examined for its ability to improve working memory in monkeys.

Materials And Methods: Clonidine (0.116-34.

View Article and Find Full Text PDF
Article Synopsis
  • Muscarinic M1 agonists like WAY-132983 show promise for enhancing cognitive function in Alzheimer's patients by reducing errors caused by scopolamine in various animal models.
  • WAY-132983 was linked to significant side effects, such as increased salivation and hypothermia, particularly at higher doses, but cognitive improvements were noted at lower doses.
  • The compound demonstrated lasting cognitive benefits in both mice and aged primates, suggesting its potential as a therapeutic option for addressing cognitive deficits in Alzheimer’s disease with manageable side effects.
View Article and Find Full Text PDF